Mutual of America Capital Management LLC Sells 6,320 Shares of R1 RCM Inc. (NASDAQ:RCM)

Mutual of America Capital Management LLC trimmed its position in R1 RCM Inc. (NASDAQ:RCM) by 5.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 120,950 shares of the healthcare provider’s stock after selling 6,320 shares during the period. Mutual of America Capital Management LLC’s holdings in R1 RCM were worth $1,278,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of RCM. Headlands Technologies LLC bought a new position in R1 RCM in the third quarter valued at $36,000. ANTIPODES PARTNERS Ltd grew its holdings in shares of R1 RCM by 429.5% in the 4th quarter. ANTIPODES PARTNERS Ltd now owns 5,623 shares of the healthcare provider’s stock valued at $59,000 after acquiring an additional 4,561 shares in the last quarter. Salem Investment Counselors Inc. acquired a new stake in shares of R1 RCM in the fourth quarter valued at about $61,000. Van ECK Associates Corp increased its position in shares of R1 RCM by 28.5% in the third quarter. Van ECK Associates Corp now owns 5,097 shares of the healthcare provider’s stock valued at $77,000 after acquiring an additional 1,130 shares during the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in R1 RCM during the third quarter worth about $189,000. 61.10% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at R1 RCM

In related news, President John M. Sparby sold 10,046 shares of the firm’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $14.33, for a total value of $143,959.18. Following the transaction, the president now owns 265,986 shares in the company, valued at $3,811,579.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 36.80% of the company’s stock.

R1 RCM Stock Performance

Shares of R1 RCM stock opened at $11.91 on Tuesday. R1 RCM Inc. has a 52-week low of $8.87 and a 52-week high of $18.70. The firm has a 50-day moving average of $12.75 and a 200-day moving average of $11.48. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.83 and a quick ratio of 1.83.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Barclays reaffirmed an “equal weight” rating and set a $14.00 price target on shares of R1 RCM in a research report on Wednesday, February 28th. Morgan Stanley reiterated an “overweight” rating and issued a $17.00 price target on shares of R1 RCM in a research note on Tuesday, March 26th. Leerink Partnrs restated an “outperform” rating on shares of R1 RCM in a research note on Monday, February 26th. Guggenheim cut their target price on shares of R1 RCM from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, April 5th. Finally, KeyCorp restated a “sector weight” rating on shares of R1 RCM in a research note on Wednesday, April 10th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.87.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.